Odyssey Therapeutics Acquires Rahko

Odyssey Therapeutics, a Boston based company developing next-generation precision medicines for patients with inflammatory diseases and cancer has acquired a majority stake in Rahko. The value of the transaction has not been made public. Odyssey is a new pharmaceutical startup that just received a Series A venture investment of $218 million earlier this month and […]

The post Odyssey Therapeutics Acquires Rahko appeared first on Quantum Computing Report.